ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011